This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharmareps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharmareps to provide that information. Where to start?
IN SUMMARY : When patients return to doctor’s offices will HCP’s have time to go online with every drug company that requests an online detail? Will patients be happy with telehealth once they feel it’s safe to return to physicians’ offices? As for patients?
For many patients in Malaysia, accessing essential medications can be a financial burden. For pharma sales reps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country. Slowly but surely, they began to see the value.
QUICK READ: Patients are returning to their doctor’s office, and it’s not uncommon for appointments, or routine visits, to be scheduled weeks or months in advance. I talked to some thought leaders, and they said that they don’t have time for either virtual patient visits or online pharma detailing.
Counterfeit medicines aren’t just a risk to patients’ health – they’re a blow to the industry’s reputation and our efforts to promote genuine, high-quality treatments. They often look like the real thing, making it hard for patients to tell the difference. What Are Counterfeit Medicines?
Instead of focusing on one product at a time, this approach helps pharmareps present a range of options that work together. Imagine walking into a pharmacy and seeing not just one medicine for diabetes but a whole set – insulin pens, oral medications, glucose monitors, and patient education leaflets. What is Portfolio Selling?
Globally, HCPs used digital channels mainly for personal learning and development (77%), followed by video conferencing for professional networking (68%), and telemedicine/telehealth practice with patients (63%). Since the beginning of the pandemic, the interactions of traditional in-person pharma representatives have declined steeply.
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharmareps.
Most HCPs said pharma companies are increasingly providing education on how to better treat patients remotely and help them manage their conditions in light of COVID-19. indicates that many patients and HCPs expect these changes are here to stay. The Challenges for Pharma. Adding Value in a Changed Value Equation.
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
These are dynamic factors, playing out differently across specialty groups and stages of the patient journey, as well as the condition being treated. Clarivate’s Taking the Pulse series of global physician studies is designed to help companies better support their physician customers in caring for patients. In contrast, half of U.S.
Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it? Where and how you message HCPs and patients must synchronize with when they are engaged.
Some of the questions we quizzed the physicians with focused on their thoughts around interactions with pharmareps. And the responses suggest an increasingly difficult future for the reps working in the EU5 markets. Our research reinforced that physicians are using multiple, varied channels in Europe.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. We have yet to talk about the increased level of competition that modern reps have to deal with. We have yet to talk about the increased level of competition that modern reps have to deal with.
Enhancing communication across care teams and improving multi-site operations with features such as video conferencing, a digital whiteboard and RxVantage calendar integration to more efficiently connect healthcare providers with relevant pharmareps. Learn more at patientpoint.com.
The days when a pharmarep can walk into any doctors' office at a specific time and expect to see the doctor if they were patient enough, could soon be a distant memory.
Pharmaceutical representatives (pharmareps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.
For those of us in ethical pharma, it wasn't just about promoting a medication; it was about educating healthcare providers on the extensive research and innovation that went into developing our products. We had to communicate the long-term benefits and the commitment to patient safety that our company stood for.
Also, already before the COVID-19 pandemic, many physicians began to restrict visits from pharmareps in some way, and the majority of offices had variable access policies governing pharmarep visits. Medical device sales reps are facing the same challenges and this is why this subject is so important.
They also need to know which conditions each medication treats and accurately convey their therapeutic benefits, safety profiles, possible side effects, and the most recent data available related to patient outcomes. Even the most experienced pharmareps need time to learn product specs, sales processes, and corporate culture.
While digital channels are gaining traction, there’s an interesting paradox HCPs still place immense value on face-to-face interactions with pharmareps. The pharmaceutical industry is going through a transformative period when it comes to engaging with healthcare providers (HCPs).
For pharmareps, understanding the market and staying prepared with stock availability is key to turning these breaks into long-term gains. This shortage led to concerns among healthcare providers and patients, highlighting the importance of reliable supply chains [ source ].
Meet Wei Wei isn't your typical high-flying pharmarep. The truth is, Wei used to be that kind of rep. The doctor, a kind but weary woman, explained how she had to turn patients away because they couldn't afford the medications he was promoting. He meticulously studied the clinic's patient records and medication usage.
Discovering healthcare gaps, barriers, and intervention points using online patient journey mapping With the increased focus on patient-centricity in Pharma, getting a holistic view of the patient journey is becoming a must-have for teams looking to understand how their product or service will impact patient care.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharmareps and medical science liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients. Get stakeholder buy in on the “why”.
Our workstation is comprised of our computer and the patient interface unit, which is the unit that connects all the cables to the catheters and a radio frequency generator. There is a little bit of patient interaction. When the patient comes, they are conscious. We had pharmareps come through.
Point-of-Care marketers had to make a lot of adjustments as the pandemic completely upended the experience of patients seeing their doctor and getting their medications. While POC is proven to drive brand volume, we collectively can make the most impact when we put the needs of patients first. Encourage Patient-HCP Interactions.
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.
Despite these challenges, pharmaceutical sales reps play a crucial role in driving revenue for their companies and promoting life-saving medication to patients. You also deal with the challenges of an ever-changing industry landscape, including stiff competition from generic drugs and strict regulation policies.
Is this product where you talk to patients as well or do you only specifically talk to providers? I look at patients that have been in pain for years and simply what they are implanting in this lady that maybe is 70 years old. It was still considered patient interfacing, but I didn’t make as much as I did in surgical.
Eh, you know lah, selling medicine here isn't like anywhere else," says Amir, a veteran pharmarep, as he expertly pulls a stream of tea between two cups. As a pharmarep, you need to be able to switch gears faster than a Myvi weaving through KL traffic. Highlight how your products are tailored for Malaysian patients.
It’s the MedTech versus medical devices, and we have the pharma division. A lot of folks do know pharma sales, pharmareps, Big Pharma, or however you want to describe it, but MedTech is a space that’s very comprehensive. I will start from a macro level. Johnson & Johnson is comprised of two divisions.
Pharmaceutical sales representatives (commonly known as “pharmareps” or “drug reps”) are responsible for promoting and educating healthcare providers about their company’s products, with the ultimate goal of increasing product sales and market share.
From cutting-edge training techniques that break the mold, to the latest industry trends making waves, and the career development hacks every pharmarep should know – we've got it all covered. You need to comprehend and convey how these products can truly make a difference in patients' lives.
Look for brands to produce videos featuring Key Opinion Leaders (KOLs), DOLs, clinical trial data, excerpts from congress presentations, and mechanism of action (MoA) animations delivered by social media, by email, and face-to-face by pharmareps to open clinical conversations. Look for TikTok to merchandise the 4.7
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content